[{"address1": "1210-1220 Washington St.", "address2": "Suite 210", "city": "Newton", "state": "MA", "zip": "02465", "country": "United States", "phone": "617 344 4190", "website": "https://acumenpharm.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate Sabirnetug (ACU193), a recombinant humanized immunoglobulin gamma 2, which has completed the INTERCEPT-AD phase 1 clinical trial and in ALTITUDE-AD phase 2 clinical trial to target soluble amyloid-beta oligomers. It has a collaboration and license agreement with Halozyme, Inc. for the development of a subcutaneous formulation of Sabirnetug. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Newton, Massachusetts.", "fullTimeEmployees": 61, "companyOfficers": [{"maxAge": 1, "name": "Mr. Daniel J. O'Connell M.B.A.", "age": 54, "title": "CEO & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 1047590, "exercisedValue": 0, "unexercisedValue": 1034567}, {"maxAge": 1, "name": "Dr. James  Doherty Ph.D.", "age": 56, "title": "President & Chief Development Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 730785, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Matt  Zuga", "title": "CFO & Chief Business Officer", "fiscalYear": 2024, "totalPay": 703157, "exercisedValue": 0, "unexercisedValue": 254161}, {"maxAge": 1, "name": "Dr. Grant A. Krafft Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "totalPay": 42000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Caleb E. Finch Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William L. Klein Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Russell  Barton M.S.", "age": 66, "title": "Chief Operating Officer", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 223680, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kelly  Carranza", "title": "Vice President, Finance & Accounting and Corporate Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Alex  Braun M.B.A.", "title": "VP & Head of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Derek M. Meisner Esq., J.D.", "age": 53, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 752945, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 6, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.9, "open": 1.92, "dayLow": 1.735, "dayHigh": 1.92, "regularMarketPreviousClose": 1.9, "regularMarketOpen": 1.92, "regularMarketDayLow": 1.735, "regularMarketDayHigh": 1.92, "payoutRatio": 0.0, "beta": 0.237, "forwardPE": -1.2287582, "volume": 282769, "regularMarketVolume": 282769, "averageVolume": 337003, "averageVolume10days": 275770, "averageDailyVolume10Day": 275770, "bid": 1.85, "ask": 1.92, "bidSize": 2, "askSize": 2, "marketCap": 115089512, "fiftyTwoWeekLow": 0.855, "fiftyTwoWeekHigh": 3.36, "allTimeHigh": 26.98, "allTimeLow": 0.855, "fiftyDayAverage": 1.7434, "twoHundredDayAverage": 1.37177, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 610039, "profitMargins": 0.0, "floatShares": 35610511, "sharesOutstanding": 60573425, "sharesShort": 1332676, "sharesShortPriorMonth": 1357015, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.022, "heldPercentInsiders": 0.070310004, "heldPercentInstitutions": 0.66855, "shortRatio": 2.7, "shortPercentOfFloat": 0.0297, "impliedSharesOutstanding": 61217823, "bookValue": 1.933, "priceToBook": 0.9725815, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -136664992, "trailingEps": -2.27, "forwardEps": -1.53, "enterpriseToEbitda": -0.004, "52WeekChange": -0.40993786, "SandP52WeekChange": 0.1198014, "quoteType": "EQUITY", "currentPrice": 1.88, "targetHighPrice": 10.0, "targetLowPrice": 4.0, "targetMeanPrice": 6.75, "targetMedianPrice": 6.5, "recommendationKey": "none", "numberOfAnalystOpinions": 4, "totalCash": 143368992, "totalCashPerShare": 2.367, "ebitda": -143920992, "totalDebt": 30101000, "quickRatio": 5.789, "currentRatio": 5.969, "debtToEquity": 25.71, "returnOnAssets": -0.39056998, "returnOnEquity": -0.7571, "grossProfits": -124207000, "freeCashflow": -71940872, "operatingCashflow": -117764000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ABOS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1625146200000, "postMarketChangePercent": 5.8510647, "postMarketPrice": 1.99, "postMarketChange": 0.110000014, "regularMarketChange": -0.02, "regularMarketDayRange": "1.735 - 1.92", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 337003, "fiftyTwoWeekLowChange": 1.025, "fiftyTwoWeekLowChangePercent": 1.1988304, "fiftyTwoWeekRange": "0.855 - 3.36", "fiftyTwoWeekHighChange": -1.4799999, "fiftyTwoWeekHighChangePercent": -0.44047618, "fiftyTwoWeekChangePercent": -40.993786, "earningsTimestamp": 1754971200, "earningsTimestampStart": 1762867800, "earningsTimestampEnd": 1762867800, "earningsCallTimestampStart": 1755000000, "earningsCallTimestampEnd": 1755000000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.27, "epsForward": -1.53, "epsCurrentYear": -2.37852, "marketState": "CLOSED", "shortName": "Acumen Pharmaceuticals, Inc.", "longName": "Acumen Pharmaceuticals, Inc.", "priceEpsCurrentYear": -0.7904075, "fiftyDayAverageChange": 0.13660002, "fiftyDayAverageChangePercent": 0.07835265, "twoHundredDayAverageChange": 0.50823, "twoHundredDayAverageChangePercent": 0.3704921, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-01", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1762555474, "regularMarketTime": 1762549202, "exchange": "NMS", "messageBoardId": "finmb_8539521", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.05263, "regularMarketPrice": 1.88, "displayName": "Acumen Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-11-08"}]